Dr Mark Garvey honoured for 'outstanding' infection prevention work
Published on 27/10/2025
Dr Mark Garvey, UHB’s Clinical Director of Infection Prevention and Control, has been honoured with a prestigious national award.
He has been presented with the Infection Prevention Society’s (IPS) Brendan Moore Award for his outstanding contribution to infection prevention.
Thie honour recognises Mark’s exceptional leadership, research, and long-standing dedication to advancing infection prevention and control (IPC).
The IPS said Mark had been an active member of IPS for more than 15 years and made a profound impact at every level of the organisation.
He was praised for his commitment to nurturing new professionals through his mentorship of colleagues at UHB, where he is Director of the Hospital Infection Research Laboratory.
The award is in memory of Dr Brendan Moore, whose achievements included the appointment of the first nurse in a hospital with the specific duty of infection control.
The IPS said: “A respected scientist and internationally recognised researcher, Mark’s work has shaped policy and practice in key areas, including water microbiology and safety, control of pseudomonas aeruginosa, and the global response to mycobacterium chimaera associated with cardiac surgery.
“Mark’s leadership during the COVID-19 pandemic was particularly noteworthy. Providing clear, evidence-based guidance during a time of great uncertainty, he was instrumental in supporting healthcare leaders across the Birmingham region and beyond.
“In awarding him the Brendan Moore Award, IPS recognises Mark’s outstanding contribution to infection prevention, his commitment to innovation, and his tireless support for the society’s mission, ensuring a world where no person is harmed by a preventable infection.”
